Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | BTN3A1 | O00481 | 4/20 | 0.46 |
| ▸ | MVD | P53602 | 3/20 | 0.35 |
| ▸ | FNTA | P49354 | 3/20 | 0.33 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19387807 | 1.00 | FDPS (0.53) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL28047113 | 0.97 | FDPS (0.50) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL27863339 | 0.97 | FDPS (0.50) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL1577193 | 0.97 | FDPS (0.50) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL9077361 | 0.97 | FDPS (0.50) | FDPSBLMTDP1BTN3A1MVD | |
| Ammonia Solution, Strong SCHEMBL28569612 | 0.97 | FDPS (0.50) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL687243 | 0.94 | FDPS (0.47) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL16855741 | 0.94 | FDPS (0.47) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL412533 | 0.94 | FDPS (0.47) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL28172217 | 0.94 | FDPS (0.47) | FDPSBLMTDP1BTN3A1MVD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 905 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4307428-B1 | NOVEL ADDITIVE FOR NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG ENERGY SOLUTION LTD (KR) | 2026-01-28 | — | — | EP | claimed |
| CN-119126506-A | Development residual gum inhibitor and method | 东莞秀博电子材料有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-20240213534-A1 | NOVEL ADDITIVE FOR NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2024-06-27 | — | — | US | claimed |
| US-20240136579-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION COMPOSITION AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2024-04-25 | — | — | US | claimed |
| CN-117720736-A | Block copolymer, hyper-dispersant, preparation method and application | 宁德安其科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| EP-4307428-A1 | NOVEL ADDITIVE FOR NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG Energy Solution, Ltd. (KR) | 2024-01-17 | — | — | EP | claimed |
| EP-4307427-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION COMPOSITION AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG Energy Solution, Ltd. (KR) | 2024-01-17 | — | — | EP | claimed |
| CN-117203817-A | Novel additive for nonaqueous electrolyte and lithium secondary battery including the same | 株式会社LG新能源 | 2023-12-08 | — | — | CN | claimed |
| CN-117157796-A | Nonaqueous electrolyte composition and lithium secondary battery comprising same | 株式会社LG新能源 | 2023-12-01 | — | — | CN | claimed |
| EP-3675266-B1 | BATTERY CELL IN WHICH GELLED ELECTROLYTE COMPONENT IS INCLUDED IN PORE OF SEPARATOR CONFIGURING ELECTRODE ASSEMBLY | LG ENERGY SOLUTION LTD (KR) | 2023-09-20 | — | — | EP | claimed |
| CN-115772202-A | Steroid compound and application thereof | 广州润尔眼科生物科技有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-107851845-B | Battery cell including gel electrolyte component in hole of separator constituting electrode assembly | 株式会社LG化学 | 2022-02-18 | — | — | CN | claimed |
| EP-3675266-A1 | BATTERY CELL IN WHICH GELLED ELECTROLYTE COMPONENT IS INCLUDED IN PORE OF SEPARATOR CONFIGURING ELECTRODE ASSEMBLY | LG CHEM, LTD. (KR) | 2020-07-01 | — | — | EP | claimed |
| EP-3316380-B1 | BATTERY CELL IN WHICH GELATION ELECTROLYTE SOLUTION COMPONENT IS INCLUDED IN PORE OF SEPARATOR CONFIGURING ELECTRODE ASSEMBLY | LG CHEMICAL LTD (KR) | 2020-04-15 | — | — | EP | claimed |
| US-20180212273-A1 | BATTERY CELL IN WHICH GELATION ELECTROLYTE SOLUTION COMPONENT IS INCLUDED IN PORE OF SEPARATOR CONFIGURING ELECTRODE ASSEMBLY | LG CHEM, LTD. (KR) | 2018-07-26 | — | — | US | claimed |
| EP-3316380-A1 | BATTERY CELL COMPRISING GELLED ELECTROLYTE COMPONENT IN AIR PORE OF SEPARATION FILM CONSTITUTING ELECTRODE ASSEMBLY | LG Chem, Ltd. (KR) | 2018-05-02 | — | — | EP | claimed |
| CN-107851845-A | Battery cell including gel electrolyte component in hole of separator constituting electrode assembly | 株式会社LG化学 | 2018-03-27 | — | — | CN | claimed |
| US-5639653-A | ADMINISTERING MONOALKYL- OR ALKENYL-PYROPHOSPHATE TO MAMMAL TO STIMULATE LYMPHOCYTE CELL GROWTH AND ENHANCE IMMUNE RESPONSE | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSTIY (US) | 1997-06-17 | — | — | US | claimed |
| US-4309364-A | Diphosphonates | SYMPHAR S.A. (CH) | 1982-01-05 | — | — | US | claimed |
| US-4057664-A | Process for the production of quick-curing epoxide resin coatings which are resistant to chemicals and to weathering | CIBA-GEIGY CORPORATION (US) | 1977-11-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240213534-A1 | NOVEL ADDITIVE FOR NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING SAME | SLC8A1, CACNA1S, CACNA1F | FDPS 4865/4885BLM 579/4885TDP1 648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.